Genmab | GEN - Ebitda





Ebitda تغيير تاريخ
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 3.86B 1.28B 2026-03
argenx SE USD 427M 22.88M 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Demant DKK 2.8B 47M 2026-06
Exelixis USD 255.4M 2.89M 2026-06
Fresenius Medical Care EUR 843.66M 19.66M 2026-06
Genmab DKK 401M 186M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GN Store Nord DKK 352M 139M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -148.3M 165.88M 2026-03
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.6B 69M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
UCB EUR 1.6B 570M 2025-12